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OBJECTIVE: To investigate the effect of elemene on the radiosensitivity of A549 cells and its possible molecular
mechanism.
METHODS: Apoptosis of A549 cells was detected by flow cytometry and fluorescence microscopy. The effect of
double-strand break (DSB) damage repair in A549 cells was evaluated using the neutral comet assay. Protein
expression levels were detected using western blotting, and the correlation between protein levels was
analyzed.
RESULTS: Elemene exhibited a radiosensitizing effect on A549 cells. The level of apoptosis induced by elemene
combined with radiation was significantly greater (po0.01) than that elicited by either radiation or elemene
alone. Following radiation and subsequent repair for 24 h, the tail intensity of A549 cells treated with a
combination of elemene and radiation was greater than that of cells treated with either elemene or radiation
alone (po0.01). This result indicates that elemene inhibits cellular DSB repair. Both elemene combined with
radiation and radiation alone decreased the protein expression of DNA-PKcs and Bcl-2 compared to elemene
alone (po0.01), while p53 protein expression was increased (po0.01). A negative correlation was observed
between DNA-PKcs and p53 expression (r=-0.569, p=0.040), while a positive correlation was found between
DNA-PKcs and Bcl-2 expression (r=0.755, p=0.012).
CONCLUSIONS: Elemene exhibits a radiosensitizing effect on A549 cells, and its underlying molecular
mechanism of action may be related to the downregulation of DNA-PKcs gene expression.
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Lung cancer is one of the most common malignant tumors,
and radiotherapy is the prevailing method of choice for
treatment (1), especially for middle- to late-stage lung cancer.
Radiation works by damaging the DNA of cancerous cells
and altering apoptosis-related genes or proteins, leading to
cell death. Improving the radiosensitivity of tumor cells is a
significant factor that would improve the efficacy of
radiotherapy.
DNA-dependent protein kinase (DNA-PK) is an important
enzyme that participates in DNA damage repair and has
become the main target of radiation sensitivity interventions
(2-4). The catalytic subunit (cs) of DNA-PK affects cellular
radiosensitivity by regulating the phosphorylation of DNA
damage repair-related proteins (5). Thus, inhibition of DNA-
PKcs gene expression can block DNA double-strand break
(DSB) repair and improve cellular radiosensitivity.
Cellular apoptosis is the core characteristic of radio-
therapy, and regulation of this process thus plays an
important role in cellular radiosensitivity (6,7). Previous
studies have shown that apoptosis-related genes, such as
phosphoprotein (p53), p16, B-cell lymphoma-2 (Bcl-2), and
erythroblastic leukemia viral oncogene homolog 2 (erbB-2),
are associated with tumor radiosensitivity (8,9), especially
p53 and Bcl-2. It has also been reported that elemene
interacts with the frontier orbitals of DNA bases to form
complexes between DNA molecules. Specifically, Jiang et al.
(10) showed that elemene increases the radiosensitivity of
A549 cells, the mechanism for which may be related to the
upregulation of p53, downregulation of Bcl-2, and induction
of cellular apoptosis.
Elemene, which is extracted from Zingiberaceae plants
(Curcuma aromatica Salisb.), is a non-cytotoxic antitumor
compound that can improve the radiosensitivity of tumor
cells (11). Results of an in vitro study showed that elemene
increased the radiosensitivity of renal carcinoma cells,
tongue squamous cancer cells, and non-small cell lungDOI: 10.6061/clinics/2015(08)05
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cancer cells (10,12,13). Animal experiments further showed
that elemene exhibited radiotherapy-sensitizing effects in
many types of tumor cells, such as transplanted murine U14
tumors, kidney cancer GRC-1 cells, and tongue squamous
carcinoma Tca-8113 cells (13-15). In addition, beta elemene
enhances A549 cell radiosensitivity through enhancement of
DNA damage and suppression of DNA repair (16).
In the current study, A549 cells were irradiated following
elemene treatment, and the changes in expression of the
apoptosis-related genes Bcl-2 and p53 as well as the double-
stranded DNA damage repair-related gene DNA-PKcs were
evaluated. These experiments were conducted to further
understand elemene’s molecular mechanism of action in
enhancing radiation sensitivity of A549 cells.
’ MATERIALS AND METHODS
Cell culture
The human lung adenocarcinoma A549 cell line was
purchased from the Chinese Academy of Medical Sciences
(CAMS) Cell Center and passaged at the Second Affiliated
Hospital of Dalian Medical University Center Laboratory.
The cells were cultured in RPMI 1640 medium containing
10% inactivated fetal bovine serum (FBS) at 37 ˚C under an
atmosphere of 5% CO2 and saturated humidity. The cells
were subcultured when they reached the exponential phase.
Reagents and instruments
Elemene (0.1 g/20 mL), which was obtained from DaLian
JinGang Pharmaceutical Co. Ltd. (China), was dissolved in
RPMI 1640 medium to final working concentrations of 10
and 20 mg/mL before use. RPMI 1640 medium was obtained
from Gibco (USA); FBS was obtained from TianJin TBD
Biotechnology Company (China); p53 and Bcl-2 antibodies
were obtained from Santa Cruz (USA, 1:1,000); and DNA-
PKcs antibody (1:2,000), anti-human b-actin mouse mono-
clonal antibody and histone H1 internuclear internal
reference antibodies (1:200) were obtained from Neomarker
(USA). The Jim-X half-dry transfer electrophoresis apparatus
was obtained from DaLian JingMai Biotechnology Co. Ltd.
(China). The flow cytometer was purchased from the Gene
Company (USA). The CK2 type inverted microscope was
obtained from Olympus (Japan). The BX51 type fluorescent
microscope was also obtained from Olympus (Japan).
Irradiation conditions
Cell irradiation was performed using the Varian 2300C/D
medical linear accelerator (Varian Companies, USA) with a
coverage field of 20 cm  20 cm. The culture dish was
placed in the radiation field above 1.5 cm of organic glass.
Cells with irradiated with 6 MV X-ray irradiation at a dosage
rate of 300 cGy/min, a rack angle of 180 ˚ , and source-to-
surface distance (SSD) of 100 cm.
Clonogenic assay
Logarithmic-growth phase cells were inoculated in a
60-mm culture dish. After adherence, the cells in the drug
and combined irradiation groups were cultured in the
presence of 10 or 20 mg/mL elemene and seeded in culture
plates at 100 cells/well for 24 h. The cells were exposed to 0,
2, 4, 6, 8, and 10 Gy of irradiation and cultured for another 14
days. The number of cell clones viewed under a low
magnification microscope was 50. The plating efficiency
(PE) was calculated relative to the control group (0 Gy), and
the survival fraction (SF) of each group was calculated as
follows:
SER=control group (D0, Dq)/experimental group (D0, Dq).
Morphological assessment of apoptosis
The cells were treated as follows: the control group
received RPMI 1640 medium; the radiation group received
a radiation dose of 4 Gy; the drug group was treated with 10
or 20 mg/mL elemene; and the drug plus radiation group
was treated with 10 or 20 mg/mL elemene followed by a
radiation dose of 4 Gy. Following incubation with elemene,
the exponentially growing cells were irradiated as described
above. Samples of 3  105 cells were then collected from
each group, treated with pancreatic enzyme digesting cells,
rinsed twice with PBS, and centrifuged at 1,000 rpm for
5 min. The SF was determined using the following equation:
SF=colony number/(plating cell number  PE).
The dose survival curve was fitted using the linear-
quadratic (LQ) function model S=e-(ad+bd2) (17) for calculat-
ing radiobiological parameters, including the sensitivity
enhancement ratio (SER), SER of the mean lethal dose (D0)
SERDq, and SER of the quasi-threshold dose (Dq) SERD0.
Nuclear morphology was examined using fluorescence
microscopy following Hoechst 33342 staining (final concen-
tration 8 mg/mL) for 15 min at 37 ˚C. Imaging was
performed using an Olympus BX-51 fluorescent microscope
with appropriate filter cubes. The excitation and emission
wavelengths were 350 nm 460 nm, respectively.
Apoptosis standard
Normal cells demonstrated uniform dispersion of low-
density fluorescence, while apoptotic cells showed high-
density fluorescence, characterized by a bright blue hue.
Assessment of apoptosis
The cells used were grouped and treated as specified
above. Then, samples of 3  105 cells were collected from
each group, treated with pancreatic enzyme digesting cells,
rinsed twice with PBS, and centrifuged at 1,000 rpm for
5 min. The cells were treated with 100 mL 2% Triton X-100 for
20 min, rinsed twice with PBS, and centrifuged at 1,000 rpm
for 5 min. Next, 200 mL of DNA-Prep LPR reagent (Beckman-
Coulter Ltd) was added for 20 min, and the cells were rinsed
twice with PBS, followed by centrifugation at 1,000 rpm for
5 min. The cells were resuspended in PBS and 50 mg/mL
propidium iodide (PI) reagent containing 480 mL of PBS, 5 mL
of PI (5 mg /mL), and 5 mL of RNase (10 mg /mL), and
10 mL of Triton X-100 (10%) was added 30 s later. Single-cell
suspensions were analyzed by flow cytometry to determine
the cellular apoptosis rate.
Neutral comet assay
A549 cells were irradiated in the absence or presence of
elemene (10 or 20 mg/mL) and assayed immediately after
radiation or returned to the incubator for 24 h to permit
repair. The comet assays were performed immediately after
incubation with elemene, irradiation or combination treat-
ment. Tumor cells were grown on glass microscope slides
using a standard protocol (18). The slides were submerged in
lysing solution containing 30 mM ethylenediaminetetraacetic
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acid (EDTA) and 0.5% sodium dodecyl sulfate (SDS, pH 8.3)
for 1.5 h at 37 ˚C. Following lysis, the slides were rinsed three
times in Tris-borate-EDTA (TBE) buffer consisting of 90 mM
Tris, 90 mM boric acid, and 2 mM EDTA, pH 8.5, and stored
overnight in TBE buffer at 4 ˚C. Slides were transferred to an
electrophoresis unit with TBE buffer and electrophoresed at
1 V/cm for 20 min. Following electrophoresis, the slides
were neutralized with 0.4 M Tris buffer (pH 7.5) and stained
with ethidium bromide (20 mg/mL). Finally, the slides were
viewed using an Olympus BX-51 fluorescent microscope
(excitation filter 549 nm, barrier filter 590 nm). Images of 50
randomly selected cells from each slide were analyzed with
Comet Assay Software Project casp-1.2.2 (University of
Wroclaw, Poland). The tail moment was used as a parameter
to assess DNA damage. The assay was completed three
separate times, and 50 cells were evaluated per experiment.
Western blot assay
Western blotting was performed to detect the expression
levels of DNA-PKcs, p53, and Bcl-2. The cells were grouped
and treated as specified above. After 24 h, western blot
analysis was performed using cytosolic fractions as pre-
viously described (19). Equal amounts of cytosolic protein
were separated on 8–12% SDS polyacrylamide denaturing
gels and transferred to nitrocellulose membranes. The
membranes were blocked in TBS-Tween (TBS-T, 10 mM
Tris-HCl, pH 7.4; 150 mM NaCl; and 0.1% Tween-20) with
5% non-fat milk for 2 h and incubated with specific primary
antibodies overnight at 4 ˚C. Finally, the membranes were
incubated with horseradish peroxidase (HRP)-conjugated
secondary antibodies at 37 ˚C for 2 h and assayed using an
enhanced chemiluminescence plus detection system.
Statistical analysis
Data were analyzed using the statistical package for the
social sciences (SPSS) v13.0 software. Data are expressed as
the mean ± standard deviation (SD). The statistical
significance of differences between groups was determined
by one-way analysis of variance (ANOVA), followed by post
hoc analysis using the least significant difference (LSD) for
multiple comparisons. The Spearman test was used for the
correlation analysis of the relationships between the expres-
sion levels of genes. The level of significance was set at
po0.05 and po0.01 for all statistical analysis.
’ RESULTS
Effects of elemene on cell radiosensitivity
The survival fraction of A549 cells decreased following
treatment with different doses of radiation and the same
concentration of elemene. Conversely, the A549 cell
survival fraction decreased in the groups treated with the
same dose of radiation in combination with increasing
concentrations of elemene (Table 1). Following treatment
with 10 or 20 mg/mL elemene, the A549 cell survival curve
shifted to the left, the shoulder area was diminished, and
the steepness of the curve increased (Figure 1). Based on
the cell survival curve, the radiobiological parameters and
radiosensitization ratio were obtained and are listed in
Table 1. These data show that, compared with the control
group, the SERD0 and SERDq values for the 10 and 20 mg/mL
elemene treatment groups were greater than 1. Furthermore,
the ratio gradually increased with an increasing drug
concentration (Table 2).
Effect of elemene on A549 cell apoptosis
Fluorescence microscopy showed that compared with the
control group, the groups treated with radiation alone and
elemene alone contained more apoptotic cells (Figure 2).
Furthermore, significantly higher apoptotic levels were
observed in the groups treated with radiation and elemene
at 10 or 20 mg/mL (Figure 2A). Flow cytometry revealed that
Table 1 - Survival fraction (%).
Group 0 Gy 2 Gy 4 Gy 6 Gy 8 Gy 10 Gy
Control 100 84.1±13.2 70.2±10.5 66.3±1.9 47.3±2.5 26.0±1.3
10 mg/ml 97.7±20.2 76.2±10.4 49.5±6.4 22.5±2.3 7.5±1.8 3.4±0.2
20 mg/ml 95.4±18.8 63.6±7.5 30.4±3.0 5.7±1.1 2.7±0.6 0.7±0.1
Cells were incubated with 10 or 20 mg/mL concentrations of elemene for 24 h and were then irradiated with 0, 2, 4, 6, 8, and 10 Gy and cultured for
another 14 days. The number of cells forming more than 50 clones was counted under the inverted microscope to calculate the cloning efficiency (CE):
CE (%)=(Clone formation average of treatment group/inoculated cell number)  100%. Survival fraction (SF)=(irritated group CE/non-irradiated group
PE)  100%. The experiment was repeated 3 times to calculate the average.
Figure 1 - Cell survival curves of A549 cells following treatment
with 0, 10 or 20 mg/mL elemene and exposure to x-ray doses from
0 to 10 Gy.
Table 2 - Radiation parameters for a single-hit multi-target
model.
Group D0 (Gy) Dq (Gy) SF2 (%) SERD0 SERDq
Control 2.54±0.24 2.68±0.25 84.6±20.9 - -
10 mg/mL 1.64±0.15 1.87±0.22 56.3±14.9 1.54±0.20 1.43±0.15
20 mg/mL 1.55±0.13 1.53±0.11 43.2±10.7 1.63±0.32 1.75±0.19
SPSS17.0 was used to calculate survival parameters including SF2
(surviving fraction of 2 Gy), D0 (mean lethal dose or final slope), and
Dq (quasi-thres-hold dose). SER (sensitization enhancement ratio). SER D0
(Dq)=control group D0 (Dq)/drug group D0 (Dq) . Three parallel samples
were set at each radiation dosage.
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Figure 2 - Elemene induces apoptosis in A549 cells. Cells were incubated with 10 or 20 mg/mL elemene for 24 h, followed by irradiation with
4 Gy X-rays and washing with PBS. (A) Cells were imaged with an Olympus BX-51 fluorescent microscope using appropriate filter cubes. (B)
Chromatin condensation was analyzed by fluorescence microscopy after DNA staining with Hoechst 3334. The results are expressed as the
mean ± SD of three independent experiments, n=3, **po0.01 compared to control, ##po0.01 compared to radiation alone.
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compared with the control group, the apoptosis rate of the
group treated with radiation alone appeared to increase, but
this was not found to be statistically significant (p40.05). The
apoptosis rate of the group treated with elemene alone did
not change (p40.05), while the apoptosis rate of the elemene
plus radiation group increased significantly (po0.01). The
rate of apoptosis increased with increasing concentrations of
elemene (Figure 2B).
Effect of elemene on DSB repair in A549 cells
Figure 3 (0 h) shows that both elemene and irradiation
alone increased the tail intensity in A549 cells, and the
degree of DSB was augmented as the elemene concentration
increased. In particular, the results showed a higher number
of DSB in the combination group than the irradiation alone
and elemene alone groups (po0.01). As shown in Figure 3
(24 h), following incubation for 24 h, the tail intensity in the
irradiation alone group returned to background levels,
while there was a significant increase in the amount of
remaining tail intensity in the combination group compared
with the irradiation alone and elemene alone groups
(po0.01).
Effects of elemene on DNA-PKcs, Bcl-2, and p53
protein expression in A549 cells
The results shown in Figure 4A revealed that in the 10 and
20 mg/mL combined treatment groups, a significant decrease in
the protein expression of DNA-PKcs (po0.01, Figure 4B) and
Bcl-2 (po0.01, Figure 4C) was observed, while the p53 protein
expression level was significantly increased (po0.01, Figure 4C).
Protein expression correlation analysis
Spearman correlation analysis showed that DNA-PKcs
and p53 protein expression was negatively correlated
(r=-0.569, po0.05), while DNA-PKcs expression was posi-
tively correlated with Bcl-2 protein expression (r=0.755,
po0.05).
’ DISCUSSION
Basic research in radiation biology has shown that
radiation therapy works mainly by damaging tumor cell
DNA and altering the expression of apoptosis-related genes
and proteins. The radiosensitivity of tumor cells relates to
their capacity to repair DSB via the related genes DNA-
PKcs, Ku70/80, and ataxia telangiectasia mutated (ATM).
Other genes known to be involved in radiosensitivity and
responsible for apoptosis regulation include p53, Bcl-2,
c-myc proto-oncogene (c-myc), and survivin (9). Beta
elemene, which is the active component of elemene, has
recently been demonstrated to enhance the radiosensitivity
of human cancer cell lines in vitro and in an animal tumor
model in vivo (16,20). In particular, beta elemene was found
to enhance radiosensitivity by influencing the cell cycle
distribution of gastric cancer MKN28 cells, and the
mechanisms responsible for this effect include the induction
of G2/M phase arrest, inhibition of sublethal damage repair,
and induction of cell apoptosis, which enhances the killing
effects of radioactive rays (21). The results of the current
study show that the SERD0 and SERDq values of A549 cells
exposed to a low concentration of cytotoxic elemene were
greater than 1. In addition, elemene enhanced the sensitivity
Figure 3 - Influence of elemene on radiation-induced DSB. A549 cells were irradiated with 4 Gy X-rays in the absence or presence of
elemene (10 or 20 mg/mL) and assayed immediately after radiation or returned to the incubator for 24 h to permit repair. Comet assays
were performed immediately after incubation with elemene treatment, irradiation, or combination treatment. Columns represent the
means of the tail moments from three independent experiments, and the bars represent the SD, **po0.01 vs. control, ##po0.01
compared to radiation alone.
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of A549 cells to radiotherapy. Cellular apoptosis is funda-
mental to radiotherapy, and its regulatory mechanism plays
an important role in cellular radiosensitivity. Apoptosis-
related genes such as p53 and Bcl-2 have important
regulatory functions in the progression of rapid apoptosis
induced by radiation therapy. For instance, a previous study
showed that the levels of the antiapoptotic genes Bcl-2 and
Bcl-xl in A549 cells decreased, while p53 expression and the
production of exosomes increased, following elemene
treatment (22). This result demonstrates that both p53 and
Bcl-2 have important regulatory actions in cervical cancer
cell apoptosis induced by radiation. A number of experi-
mental studies have further shown that elemene is involved
in regulating the expression of Bax, c-myc, p53, poly (ADP-
ribose) polymerase (PARP), survivin, and livin as well as
inducing tumor cell apoptosis (23-26). Our results showed
that, compared with the exposure alone group, the group
that received elemene combined with irradiation exhibited
increased p53 gene expression and significantly decreased
Bcl-2 gene expression, and the expression of both genes was
significantly correlated. Furthermore, elemene was shown to
regulate expression of the apoptosis-related genes Bcl-2 and
p53 and induce A549 cell apoptosis, thereby increasing cell
radiosensitivity.
Interestingly, when Bcl-2 and p53 gene expression was
significantly altered, DNA-PKcs protein expression was
significantly decreased in the combined treatment group.
This result indicates that elemene is also involved in
regulating DNA damage repair pathways. Protein kinase
activation leads to the phosphorylation of downstream
DNA repair proteins, which initiate DNA chain fracture
repair (27), and the relationship between DNA-PKcs and
radiotherapy sensitivity has been a topic of significant
research in recent years. It is well established that
inhibiting tumor cell expression of DNA-PKcs increases
radiation sensitivity. Panet al. (28) studied the relationship
between DNA-PKcs expression and radiation sensitivity in
non-small cell lung cancer cell lines, and in adenocarcino-
mas and large cell carcinomas, DNA-PKcs was shown to
be an important component regulating cellular radio-
sensitivity. This result indicates that DNA-PKcs may be
predictive of non-small cell lung cancer cell radiosensitiv-
ity. Zou et al. (29) silenced the DNA-PKcs gene of human
mammary epithelial cells (MCF10F) using small interfer-
ing RNA (siRNA) technology. Simultaneously, the expres-
sion of DNA repair-related proteins, such as DNA-PKcs,
Ku80, ATM, and p53, was decreased in these cells, while
their sensitivity increased with low doses of radiation.
Small molecule inhibitors of DNA-PKcs were also shown
to enhance radiation sensitivity of cervical cancer
cells (30). Our experimental results showed that elemene
inhibited DNA-PKcs expression in A549 cells,
reduced DNA damage repair, and increased cellular
radiosensitivity.
DNA-PKcs is a protein with a wide range of functions and
is involved in DNA damage repair, apoptosis, and V(D)J
recombination (31). Yu et al. (32) found that in non-small cell
lung cancer, high expression of DNA-PKcs increased the
activity of the DNA damage repair system. In addition,
apoptosis inhibition caused by mutant p53 and Bcl-2
expression exhibited a combined effect, which may explain
the development of resistance to radiotherapy in small-cell
lung cancer. Daido et al. (33) indicated that following
exposure to low doses of radiation, human malignant glioma
M059J cells that lack DNA-PKcs underwent massive autop-
hagic cell death that was significantly increased after
exposure to DNA-PKcs inhibitors. Furthermore, DNA-PKcs
inhibitors exert radiotherapy-sensitizing effects on glioma
cells by enhancing type II programmed cell death. Lee et al.
(34) found that p53-inducible gene 3 (PIG3) is involved in
apoptosis caused by p53 activation and that this molecule
can regulate DNA-PKcs expression. Moreover, knockdown
of PIG3 was shown to decrease the level of DNA-PKcs in
cells. Our study further addressed the correlation between
DNA-PKcs, Bcl-2, and p53 expression, and the results
showed that DNA-PKcs expression was significantly posi-
tively correlated with that of Bcl-2 (r=0.755, po0.05) and
significantly negatively correlated with p53 (r=0.569,
po0.05). We further showed that DNA-PKcs was closely
related to apoptosis and that elemene increased apoptosis of
A549 cells and strengthened cellular radiosensitivity by
inhibiting DNA-PKcs expression.
In summary, elemene exhibits radiotherapy-sensitizing
effects on lung adenocarcinoma A549 cells, and its mechan-
ism of action involves the upregulation of p53 and down-
Figure 4 -Western blot analysis of the protein levels of Bcl-2, p53
and DNA-PKcs. A549 cells were irradiated with 4 Gy X-rays
following treatment with 10 or 20 mg/mL elemene for 24 h.
Proteins were extracted and separated by SDS-PAGE. (A) Levels of
Bcl-2, p53 and DNA-PKcs were quantitated by densitometry, and
the ratios of the three proteins are displayed. Values represent
the mean ± SD, n=3, **po0.01 compared to the control,
##po0.01 compared to radiation alone. Elemene inhibited the
protein expression of (B) DNA-PKcs and (C) Bcl-2 and promoted
the protein expression of p53. Key: 1, Control; 2, irradiation; 3,
10 mg/mL; 4, 20 mg/mL; 5, 10 mg/mL+ irradiation; 6, 20 mg/mL+
irradiation.
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regulation of Bcl-2 to promote cell apoptosis, as well as the
downregulation of DNA-PKcs to inhibit DSB repair. How-
ever, the specific mechanism of action of elemene requires
further elucidation.
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